Prolonged Neuromuscular Blockade Following Succinylcholine Administration to a Patient with a Reduced Butyrylcholinesterase Activity

Table 1

Genotype—Phenotype Relation of Butyrylcholinesterase (BCHE).

Nucleotide Exchange	Amino Acid Change	Phenotype Variants	Reference
98A>𝐺	Tyr-33-Cys	Silent	[1]
109C>𝑇	Pro-37-Ser	Silent	[1]
209A>𝐺	Asp-70-Gly	Atypical	[2]
350T>𝐴𝐺	Gly-117-Gly+	Silent	[3]
355C>𝑇	Gln-119-STOP	Silent	[4]
375A>𝑇	Leu-125-Phe	Silent	[1]
383A>𝐺	Tyr-128-Cys	Silent	[5]
424G>𝐴	Val-142-Met	H	[6]
510T>𝐺	Asp-170-Glu	Silent	[1]
551C>𝑇	Ala-184-Val	Fluoride-Resistant	[7, 8]
592A>𝐺	Ser-198-Gly	Silent	[1]
596C>𝑇	Ala-199-Val	Silent	[9]
601G>𝐴	Ala-201-Thr	Silent	[1]
728C>𝑇	Thr-243-Met	Fluoride-Resistant	[10]
811G>𝑇	Glu-271-STOP	Silent	[1]
1093G>𝐴	Gly-365-Arg	Silent	[11]
1169G>𝑇	Gly-390-Val	Fluoride-Resistant	[10]
1294G>𝑇	Glu-432-STOP		[7]
1411T>𝐶	Trp-471-Arg	Silent	[1]
1490A>𝑇	Glu-497-Val	J	[12]
1500T>𝐴	Tyr-500-STOP	Silent	[1]
1543C>𝑇	Arg-515-Cys	Silent	[11]
1553A>𝑇	Gln-518-Leu	Silent	[1]
1615G>𝐴	Ala-539-Thr	K	[13]